Advanced Algorithmic Live Trading Signals for Crypto & Stocks

Gain a Competitive Edge with Advanced Algorithmic Live Trading Signals for Crypto & Stocks. Enhance your trading strategy and maximize your profit potential with our free buy and sell signals. Our cutting-edge algorithms provide real-time market insights and help you make informed decisions. Explore our live market signals for the Nasdaq and Oslo stock exchanges and take your trading to the next level.

Stock Gainers

Symbol	Price	Change %	Volume
GOOG	173.64	9.93%	49.99M
DTST	5.10	9.91%	47 885.00
CONL	56.76	9.83%	1.20M
BMR	6.04	9.82%	497 695
FTEK	1.240	9.80%	148 770
QUIK	14.41	9.75%	352 376
FGI	1.130	9.71%	16 774.00
IMTE	2.39	9.63%	22 633.00
ENVX	6.40	9.50%	3.81M
TRVI	2.78	9.45%	34 695.00

Nasdaq : 2.12 %

Dow Jones : 0.46 %

S&P 500 : 1.11 %

Shanghai: 1.17 %

Hongkong: 2.12 %

ASX: -1.26 %

CAC40: 0.75 %

FTSE 100: 0.89 %

IPC Mexico: 1.54 %

Nikkei 225: 0.81 %

Nifty 50: -0.67 %

IBOVESPA: 1.57 %

Stock Losers

Symbol	Price	Change %	Volume
CCRD	11.98	-1.40%	10 577.00
ROKU	56.46	-10.11%	16.71M
RENB	1.525	-10.27%	1.02M
GGLS	13.80	-10.27%	148 084
KTRA	0.142	-10.38%	50.20M
SWVL	10.92	-10.42%	30 388.00
VERO	0.681	-10.51%	21 661.00
CAUD	0.392	-10.51%	380 438
CSLR	0.375	-10.63%	414 019
SBET	1.060	-10.92%	52 376.00

Live Signals

NasdaqStock Exchange

10 Last Buy Signals

Ticker	Time	TSS	@	Price Now	Return
WDAY	Apr 26 - 19:49	1 min	$251.23	$251.09	-0.06%
SYM	Apr 26 - 19:49	1 min	$40.40	$40.38	-0.04%
JAZZ	Apr 26 - 19:49	1 min	$109.96	$110.00	0.04%
TLT	Apr 26 - 19:49	2 min	$88.22	$88.22	0.00%
XRAY	Apr 26 - 19:48	2 min	$30.58	$30.58	0.00%
MPWR	Apr 26 - 19:47	3 min	$675.43	$674.36	-0.16%
EXEL	Apr 26 - 19:47	3 min	$23.70	$23.69	-0.06%
VTRS	Apr 26 - 19:44	6 min	$11.60	$11.62	0.13%
SMTC	Apr 26 - 19:44	6 min	$35.64	$35.69	0.14%
VXUS	Apr 26 - 19:44	6 min	$59.32	$59.34	0.03%

Oslo Stockexchange

10 Last Buy Signals

Ticker	Time	TSS	@	Price Now	Return
HAFNI.OL	Apr 26 - 13:37	373 min	NOK84.10	NOK83.85	-0.30%
HSHP.OL	Apr 26 - 13:34	376 min	$88.20	$89.00	0.91%
SCHB.OL	Apr 26 - 13:32	378 min	NOK314.40	NOK311.40	-0.95%
HAVI.OL	Apr 26 - 13:32	379 min	NOK6.99	NOK6.80	-2.72%
SDRL.OL	Apr 26 - 13:30	380 min	$546.00	$548.00	0.37%
BRG.OL	Apr 26 - 13:30	380 min	NOK190.00	NOK187.80	-1.16%
NHY.OL	Apr 26 - 13:30	380 min	NOK70.32	NOK69.94	-0.54%
BEWI.OL	Apr 26 - 13:26	384 min	NOK29.85	NOK29.75	-0.34%
FLNG.OL	Apr 26 - 13:25	385 min	NOK289.40	NOK289.80	0.14%
DOFG.OL	Apr 26 - 13:25	386 min	$79.55	$79.65	0.13%

Crypto

10 Last Buy Signals

Ticker	Time	TSS	@	Price Now	Return
RADUSD	Apr 26 - 19:48	2 min	$1.760	$1.767	0.41%
P2PSUSD	Apr 26 - 19:44	7 min	$179.40	$179.40	0.00%
CREAMUSD	Apr 26 - 19:44	7 min	$43.95	$44.06	0.24%
LINKUSD	Apr 26 - 19:44	7 min	$14.67	$14.70	0.20%
AVAXUSD	Apr 26 - 19:43	7 min	$34.84	$34.98	0.40%
GNSUSD	Apr 26 - 19:43	7 min	$3.42	$3.43	0.29%
WEMIXUSD	Apr 26 - 19:43	7 min	$1.670	$1.670	0.00%
FARMUSD	Apr 26 - 19:41	9 min	$84.05	$84.26	0.25%
TETUSD	Apr 26 - 19:40	10 min	$18.75	$18.74	-0.04%
WETHUSD	Apr 26 - 19:39	12 min	$3 144.41	$3 142.88	-0.05%

Latest News

2024-04-26T19:43:00.000Z - globenewswire

Fentura Financial, Inc. Announces First Quarter 2024 Earnings (Unaudited)

Dollars in thousands except per share amounts. Certain items in the prior period financial statements have been reclassified to conform with the March 31, 2024 presentation. Dollars in thousands except per share amounts. Certain items in the prior period financial statements have been reclassified to conform with the March 31, 2024 presentation...

Full Story

2024-04-26T19:30:00.000Z - globenewswire

Nokia Oyj: Omien osakkeiden takaisinosto 26.04.2024

Nokia OyjPörssitiedote26.04.2024 klo 22.30...

Full Story

2024-04-26T19:30:00.000Z - globenewswire

Nokia Corporation: Repurchase of own shares on 26.04.2024

Nokia CorporationStock Exchange Release26 April 2024 at 22:30 EEST...

Full Story

2024-04-26T19:26:42.000Z - benzinga

What's Going On With ImmunityBio Stock?

ImmunityBio, Inc. (NASDAQ:IBRX) shares are trading higher Friday after the company announced overall survival results in its QUILT 3.055 study. The Details: ImmunityBio said the QUILT 3.055 trial shows median overall survival almost double that of standard of care chemotherapy in 2nd- and 3rd-line non-small cell lung cancer (NSCLC) patients whose cancer did not respond to checkpoint inhibitors with or without chemotherapy. "The results we noted with the completion of the QUILT 3.055 basket tria...

Full Story

2024-04-26T19:16:00.000Z - globenewswire

Oxford Square Capital Corp. Schedules First Quarter 2024 Earnings Release and Conference Call for May 2, 2024

GREENWICH, Conn., April 26, 2024 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) announced today that it will hold a conference call to discuss first quarter 2024 earnings on Thursday, May 2, 2024 at 9:00 AM Eastern time. The toll free dial-in number is 1-800-445-7795, verbal access code is OXFORD. There will be a recording available for 30 days after the call. If you are interested in hearing the recording, please dial 1-877-693-4280. The r...

Full Story

2024-04-26T19:04:23.000Z - benzinga

Intel 'Still A Work In Progress' As 'Turnaround Efforts Take Root,' Analysts Say After Q1 Disappointment

Intel Corp (NASDAQ:INTC) stock fell after reporting a first-quarter (Q1) revenue miss and weak Q2 EPS guidance. The company’s quarterly earnings of 18 cents per share beat the consensus estimate by 28.57%. However, sales of $12.72 billion missed estimates by 0.44%. Related: Intel Shares Fall On Q1 Revenue Miss, Weak Q2 EPS Guidance CEO Pat Gelsinger remains confident in company’s future, proclaiming “Intel is back.” Here's what analysts have to say about the earnings report. JPMorgan Chase anal...

Full Story

2024-04-26T18:30:08.000Z - benzinga

FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia

Friday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate to severe hemophilia B in adult patients who currently use factor IX (FIX) prophylaxis therapy or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes, and do not have neutralizing antibodies to adeno-associated virus serotype Rh74var capsid. Beqvez is a one-time treatment designed to enable hemophilia B patients to produce FIX themselve...

Full Story

2024-04-26T18:30:00.000Z - globenewswire

Bigbanki 2024. aasta I kvartali auditeerimata majandustulemused

Bigbanki brutolaenuportfell kasvas esimese kvartali lõpuks rekordilise 1,75 miljardi euroni, suurenedes kvartaliga 86 miljoni euro võrra (+5%) ja aastaga 325 miljoni euro võrra (+23%). Ärilaenude portfell kasvas kvartaliga 22 miljoni euro võrra (+4%) 600 miljoni euroni, eluasemelaenude portfell kasvas kvartaliga 43 miljoni euro võrra (+12%) 394 miljoni euroni ja tarbimislaenude portfell 25 miljoni euro võrra (+3%) 762 miljoni euroni...

Full Story

2024-04-26T18:30:00.000Z - globenewswire

Bigbank's Unaudited Financial Results for Q1 2024

Bigbank’s total gross loan portfolio grew to a record 1.75 billion euros by the end of the first quarter, increasing by 86 million euros (+5%) over the quarter and by 325 million euros (+23%) year-on-year. During the quarter, the corporate loan portfolio grew by 22 million euros (+4%) to 600 million euros, the housing loan portfolio by 43 million euros (+12%) to 394 million euros and the consumer loan portfolio by 25 million euros (+3%) to 762 million euros...

Full Story

2024-04-26T18:27:43.000Z - finance

Intel CEO confident in its AI future after posting soft guidance

After several steps forward with investors, it's a few steps back for Intel (INTC). Shares of the chipmaker fell 8% on Friday, following several hiccups in its first quarter results and second quarter guidance. While the company's first quarter earnings managed to surpass forecasts by $0.05, its guidance for the rest of the year came below consensus".

Full Story

At its core, trading is about making informed decisions based on data. That's why traders use various tools to help them identify trends, patterns, and signals that indicate a potential buying or selling opportunity. One such tool is live signals. In this guide, we'll explore what live signals are, how they work, and why they're an essential part of any trader's toolkit.

What Are Live Signals?

Discover Advanced Algorithmic Live Trading Signals for Crypto & Stocks. Live signals are real-time notifications that provide traders with up-to-date information about potential trading opportunities. These signals are generated by advanced algorithms that analyze market data, identifying patterns and trends in stocks, forex, and cryptocurrencies. Stay ahead of the market with our comprehensive live signals delivered through email, SMS, or our dedicated trading platform.

How Do Live Signals Work?

Maximize Your Profit Potential with Real-Time Live Signals. Our advanced algorithms analyze price movements, trading volumes, and other indicators to identify potential buying or selling opportunities. When a signal is generated, it is sent to you in real-time, empowering you to make informed trading decisions. Incorporate live signals into your trading strategy to gain a competitive edge.

Why Use Live Signals?

Unlock Trading Success with Live Signals: Real-Time Insights for Profits. Benefit from real-time information, save time by automating opportunity identification, and leverage the accuracy of advanced algorithms. Reduce risk and improve profitability by acting on timely and reliable signals. Gain a competitive advantage with our live signals.

How to Use Live Signals

Optimize Your Trading Strategy with Effective Use of Live Signals. Follow these tips for maximum impact:

Utilize multiple signals: Combine signals from different sources to confirm opportunities and minimize false positives.
Incorporate technical analysis: Combine live signals with technical analysis to strengthen your trading decisions.
Set up alerts: Stay informed about important events and market changes with customized alerts.
Develop a trading plan: Use live signals to inform your trading plan, not replace it.
Manage risk: Implement risk management strategies to protect your investments.

The Risks of Using Live Signals

Stay Informed and Be Aware of Potential Risks When Using Live Signals:

Beware of false positives: While advanced, algorithms may occasionally generate false positives that can lead to poor decisions.
Avoid over-reliance: Use live signals as part of a comprehensive trading strategy.
Be mindful of technical issues: Technical glitches can occasionally impact signal delivery.
Consider costs: Some live signal services may involve additional costs.

Conclusion

Enhance Your Trading Decisions with Advanced Algorithmic Live Signals. By incorporating live signals into your trading strategy and considering their risks, you can gain valuable insights for successful trading. Choose a reputable service, test signals on a demo account, and unlock the full potential of live signals in your trading journey.

If you're interested in using live signals for trading, it's essential to do your research and choose a reputable service. Always be sure to test the signals on a demo account before using them with real money. With the right approach, live signals can be a valuable part of any trader's toolkit.

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.

DISCLAIMER:

"Getagraph.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "Getagraph.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.